Skip to content
Trial Eligibility
Menu

Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes

NCT06948825

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this clinical trial is to evaluate the effectiveness of a 6-month lifestyle intervention compared to Metformin in postpartum women who have delivered a singleton, live born infant within the last 12 weeks to 1 year and had a pregnancy complicated by gestational diabetes. The main question this study aims to answer is: Is a Lifestyle Intervention or Metformin more effective for weight loss in postpartum women with recent gestational diabetes?

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Weight Loss
  • Gestational Diabetes Mellitus in Pregnancy
  • Postpartum Care

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
18 to 45 years
Sex
Female
Healthy volunteers
Accepted
Sponsor
George Washington University
Last updated on ClinicalTrials.gov
January 13, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

District of Columbia · 1

  • Milken Institute School of Public Health - The George Washington University · Washington D.C., DC

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.